[2] Some individuals do experience gastrointestinal side effects when taking B12 supplements, particularly when first beginning supplementation
With respect to the newness criterion, according to the applicant, TECVAYLI TM was granted BLA approval from FDA on October 25, 2022 for the treatment of adult patients with RRMM who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody
In summary, the kinetic data for the E170X mutants support a glutaredoxin-catalysed formation of GSSEtOH as well as an exclusive interaction between Glu170 and the glutathione moiety of GSSR in accordance with the glutathione-scaffold model
doi: 10.1016/J.YFRNE.2007.10.005 5 Gonzlez-OrozcoJCCamacho-ArroyoI
The lowest activity in the alpha class was shown by GST A4-4, which is also known to have modest CDNB activity 26